Latest Coronavirus Disease COVID 19 News and Research
Clinical trials of hydroxychloroquine in COVID-19 outpatients are safe
According to new research, the use of hydroxychloroquine among outpatients in clinical trials, without high-risk factors for cardiac arrhythmia, is safe.
Study reveals manifold applications of cytokine transcriptional response modules in COVID-19
In a recent bioRxiv* study, UK researchers used interleukin modules to investigate the pathology of coronavirus disease (COVID-19).
‘It’s about love and solidarity’: Mutual aid unites NYC neighbors facing COVID
Nancy Perez, a 45-year-old resident of the Brooklyn neighborhood of Bedford-Stuyvesant, contracted COVID-19 in March. She stayed quarantined in her room for a month to isolate from her two sons and grandson.
Study provides new insights into the host cellular response to SARS-CoV-2 infection
The COVID-19 pandemic caused by the new coronavirus has created an unprecedented public health challenge globally. Little was known about how the infecting cells respond to the virus and how the virus hijacks the host cellular machinery.
The color of COVID: Will vaccine trials reflect America’s diversity?
When U.S. scientists launch the first large-scale clinical trials for COVID-19 vaccines this summer, Antonio Cisneros wants to make sure people like him are included.
High ACE2 Expression on pancreatic islet cells during inflammation could explain new-onset diabetes in COVID-19
A new study suggests that the SARS-CoV-2 infection may be linked to the onset of diabetes, via the infection of pancreatic islet beta cells, which produce insulin.
Last thing patients need during pandemic: Being last to know a doctor left network
As the coronavirus spread silently through New York City early this year, Deborah Koeppel had an appointment with her cardiologist and two visits with her primary care doctor. Both physicians are members of Concorde Medical Group, a practice in Manhattan with an office conveniently located a few blocks from where Koeppel works.
Employers require COVID liability waivers as conflict mounts over workplace safety
After spending a May day preparing her classroom to reopen for preschoolers, Ana Aguilar was informed that the tots would not have to wear face masks when they came back. What's more, she had to sign a form agreeing not to sue the school if she caught COVID-19 or suffered any injury from it while working there.
Researchers track the wellbeing of British population before and during COVID-19 pandemic
The coronavirus outbreak caused life satisfaction to fall sharply, but lockdown went a long way to restoring contentment - even reducing the "wellbeing inequality" between well-off professionals and the unemployed, according to a new study.
New approach could enable wider adoption of COVID-19 testing for diagnosis in research laboratories
Clinician-scientists at Nanyang Technological University, Singapore's (NTU Singapore) Lee Kong Chian School of Medicine (LKCMedicine) have demonstrated a way to improve the speed, handling time and cost of COVID-19 laboratory tests.
Researchers identify anticoagulation agent that suppresses SARS-CoV-2 replication in vitro
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can cause acute respiratory distress syndrome, hypercoagulability, hypertension, and multiorgan dysfunction.
Scientists develop COVID-19 test to detect neutralizing antibodies with high sensitivity, specificity
According to a study published in Nature Biotechnology, the sVNT is capable of detecting the functional neutralizing antibodies (NAbs) that can block the binding of the coronavirus spike protein to the angiotensin-converting enzyme 2 (ACE2) host receptor, which mimics the virus-host interaction.
National clinical trial to test potential vaccine against SARS-CoV-2
UC San Diego Health and the Altman Clinical and Translational Research Institute, part of UC San Diego School of Medicine, will be sites for an accelerated national clinical trial to assess the efficacy and immunogenicity of a vaccine intended to protect against SARS-CoV-2, the novel coronavirus that causes COVID-19.
Olfactory cell types are most vulnerable to COVID-19 infection, shows study
Temporary loss of smell, or anosmia, is the main neurological symptom and one of the earliest and most commonly reported indicators of COVID-19.
SMCSE hosts National Symposium on Developing Socially Responsible STEM Professionals
On January 14th 2020, City's School of Mathematics, Computer Science and Engineering (SMCSE) hosted its first National Symposium on Developing Socially Responsible STEM Professionals.
Researchers identify TLR7 gene that predisposes elderly patients to severe COVID-19
Current observations suggest that the coronavirus SARS-CoV-2 causes severe symptoms mainly in elderly patients with chronic disease.
Experimental mRNA-based COVID-19 vaccine elicits protective immune responses in animals
An experimental messenger RNA (mRNA)-based vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) elicits protective immune responses in mice and non-human primates, researchers report on July 23rd in the journal Cell.
Seaweed extract outperforms remdesivir in inhibiting SARS-CoV-2 in cell studies
In a test of antiviral effectiveness against the virus that causes COVID-19, an extract from edible seaweeds substantially outperformed remdesivir, the current standard antiviral used to combat the disease.
Scientists discover how coronavirus enters cells without encountering immune system resistance
With an alarm code, we can enter a building without bells going off. It turns out that the SARS coronavirus 2 (SARS-CoV-2) has the same advantage entering cells. It possesses the code to waltz right in.
New app could help scientists to investigate the use of wearable devices for COVID-19 detection
The researchers, funded by National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre (BRC), created the Mass Science app that allows COVID-Collab study participants to connect wearables, such as Fitbit devices, and share data including heart rate, activity and sleep.
No hay comentarios:
Publicar un comentario